Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Heart Failure | Research

Serum zinc concentration in patients with myocardial infarction: a retrospective study

Authors: Atsushi Tanita, Shigeto Namiuchi, Kenta Onodera, Shinichiro Sunamura, Tsuyoshi Ogata, Kazuki Noda, Toru Takii

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

Zinc regulates the oxidative stress and inflammatory signaling cascade and affects the development and deterioration of cardiovascular disease. We investigated the prognosis of developing heart failure in patients with myocardial infarction.

Methods

Patients with myocardial infarction (n = 243) were divided using the median value of zinc concentration on admission into low (< 66 µg/dL at admission, n = 111) and high zinc group (≥ 66 µg/dL at admission, n = 132). During follow-up (mean ± SD: 734 ± 597 days; median 691 days), admission due to heart failure was observed in 12 patients: 10 and 2 cases in the low and high zinc groups, respectively.

Results

The risk of admission due to heart failure was significantly higher in the low zinc than in the high zinc group (P = 0.0043). Relative to the high zinc group, the hazard ratio for admission due to heart failure was 15.7 (95% confidence interval 1.11–221, P = 0.042) via adjusted Cox proportional hazards analysis. Even after propensity score matching, the risk of admission due to heart failure was significantly higher in the low zinc than in the high zinc group (P = 0.048).

Conclusion

Low serum zinc concentration may be a risk factor for admission due to heart failure after myocardial infarction.
Literature
1.
go back to reference Choi S, Liu X, Pan Z. Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacol Sin. 2018;39:1120–32.CrossRefPubMedPubMedCentral Choi S, Liu X, Pan Z. Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacol Sin. 2018;39:1120–32.CrossRefPubMedPubMedCentral
2.
go back to reference Liu B, Cai ZQ, Zhou YM. Deficient zinc levels and myocardial infarction: association between deficient zinc levels and myocardial infarction: a meta-analysis. Biol Trace Elem Res. 2015;165:41–50.CrossRefPubMed Liu B, Cai ZQ, Zhou YM. Deficient zinc levels and myocardial infarction: association between deficient zinc levels and myocardial infarction: a meta-analysis. Biol Trace Elem Res. 2015;165:41–50.CrossRefPubMed
4.
go back to reference Abdel-Hady E, Mohamed F, Ahmed M, Abdel-Salam M, Ayobe M. Supplementation of lipoic acid, zinc and clopidogrel reduces mortality rate and incidence of ventricular arrhythmia in experimental myocardial infarction. Front Physiol. 2021;12:582223.CrossRefPubMedPubMedCentral Abdel-Hady E, Mohamed F, Ahmed M, Abdel-Salam M, Ayobe M. Supplementation of lipoic acid, zinc and clopidogrel reduces mortality rate and incidence of ventricular arrhythmia in experimental myocardial infarction. Front Physiol. 2021;12:582223.CrossRefPubMedPubMedCentral
5.
go back to reference Gonçalves AF, Polgato BF, Fernandes AA, Ishikawa LL, Okoshi K, Bazan SGZ, et al. Zinc supplementation attenuates cardiac remodeling after experimental myocardial infarction. Cell Physiol Biochem. 2018;50:353–62.CrossRefPubMed Gonçalves AF, Polgato BF, Fernandes AA, Ishikawa LL, Okoshi K, Bazan SGZ, et al. Zinc supplementation attenuates cardiac remodeling after experimental myocardial infarction. Cell Physiol Biochem. 2018;50:353–62.CrossRefPubMed
6.
go back to reference Okabe T, Yakushiji T, Shimazu S, Saito J, Kimura T, OyamaY, et al. Serum zinc concentration in patients with acute myocardial infarction in percutaneous coronary intervention era. PLoS ONE. 2018;13:e0203074.CrossRefPubMedPubMedCentral Okabe T, Yakushiji T, Shimazu S, Saito J, Kimura T, OyamaY, et al. Serum zinc concentration in patients with acute myocardial infarction in percutaneous coronary intervention era. PLoS ONE. 2018;13:e0203074.CrossRefPubMedPubMedCentral
7.
go back to reference Yu X, Huang L, Zhao J, Wang Z, Yao W, Wu X, et al. The relationship between serum zinc level and heart failure: a meta-analysis. BioMed Res Int. 2018;2018:2739014.PubMedPubMedCentral Yu X, Huang L, Zhao J, Wang Z, Yao W, Wu X, et al. The relationship between serum zinc level and heart failure: a meta-analysis. BioMed Res Int. 2018;2018:2739014.PubMedPubMedCentral
8.
go back to reference Yoshihisa A, Abe S, Kiko T, Kimishima Y, Sato Y, Watanabe S, et al. Association of serum zinc level with prognosis in patients with heart failure. J Card Fail. 2018;24:375–83.CrossRefPubMed Yoshihisa A, Abe S, Kiko T, Kimishima Y, Sato Y, Watanabe S, et al. Association of serum zinc level with prognosis in patients with heart failure. J Card Fail. 2018;24:375–83.CrossRefPubMed
9.
go back to reference Rosenblum H, Wessler JD, Gupta A, Maurer MS, Bikdeli B. Zinc deficiency and heart failure: a systematic review of the current literature. J Card Fail. 2020;26:180–9.CrossRefPubMed Rosenblum H, Wessler JD, Gupta A, Maurer MS, Bikdeli B. Zinc deficiency and heart failure: a systematic review of the current literature. J Card Fail. 2020;26:180–9.CrossRefPubMed
10.
go back to reference Correia LC, Andrade BB, Borges VM, Clarêncio J, Bittencourt AP, Freitas R, et al. Prognostic value of cytokines and chemokines in addition to the GRACE score in non-ST-elevation acute coronary syndromes. Clin Chim Acta. 2010;411:540–5.CrossRefPubMed Correia LC, Andrade BB, Borges VM, Clarêncio J, Bittencourt AP, Freitas R, et al. Prognostic value of cytokines and chemokines in addition to the GRACE score in non-ST-elevation acute coronary syndromes. Clin Chim Acta. 2010;411:540–5.CrossRefPubMed
11.
go back to reference Buyukkaya E, Poyraz F, Karakas MF, Kurt M, Akcay AB, Akpinar I, et al. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;112:187–93.CrossRefPubMed Buyukkaya E, Poyraz F, Karakas MF, Kurt M, Akcay AB, Akpinar I, et al. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;112:187–93.CrossRefPubMed
12.
go back to reference Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol. 2003;88:257–65.CrossRefPubMed Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol. 2003;88:257–65.CrossRefPubMed
13.
go back to reference Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohono T, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2004;44:1510–20.CrossRefPubMed Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohono T, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2004;44:1510–20.CrossRefPubMed
14.
go back to reference Efeovbokhan N, Bhattacharya SK, Ahokas RA, Sun Y, Guntaka RV, Gerling IC, et al. Zinc and the prooxidant heart failure phenotype. J Cardiovasc Pharmacol. 2014;64:393–400.CrossRefPubMedPubMedCentral Efeovbokhan N, Bhattacharya SK, Ahokas RA, Sun Y, Guntaka RV, Gerling IC, et al. Zinc and the prooxidant heart failure phenotype. J Cardiovasc Pharmacol. 2014;64:393–400.CrossRefPubMedPubMedCentral
15.
go back to reference The Japanese Coronary Artery Disease (JCAD) Study Investigators. Current status of the background of patients with coronary artery disease in Japan. Circ J. 2006;70:1256–62.CrossRef The Japanese Coronary Artery Disease (JCAD) Study Investigators. Current status of the background of patients with coronary artery disease in Japan. Circ J. 2006;70:1256–62.CrossRef
16.
go back to reference Ogawa H, Kojima S. Modern state of acute myocardial infarction in the interventional era: observational case-control study-japanese acute coronary syndrome study (JACSS). J Cardiol. 2009;54:1–9.CrossRefPubMed Ogawa H, Kojima S. Modern state of acute myocardial infarction in the interventional era: observational case-control study-japanese acute coronary syndrome study (JACSS). J Cardiol. 2009;54:1–9.CrossRefPubMed
17.
go back to reference Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, et al. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J. 2013;77:934–43.CrossRefPubMed Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, et al. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J. 2013;77:934–43.CrossRefPubMed
18.
go back to reference Ritsinger V, Nystrom T, Saleh N, Lagerqvist B, Norhammar A. Heart failure is a common complication after acute myocardial infarction in patients with diabetes: a nationwide study in the SWEDEHEART registry. Eur J Prev Cardiol. 2020;27(17):1890–901.CrossRefPubMed Ritsinger V, Nystrom T, Saleh N, Lagerqvist B, Norhammar A. Heart failure is a common complication after acute myocardial infarction in patients with diabetes: a nationwide study in the SWEDEHEART registry. Eur J Prev Cardiol. 2020;27(17):1890–901.CrossRefPubMed
19.
go back to reference Peters SAE, Colantonio LD, Dai Y, Zhao H, Bittner V, Farkouh ME, et al. Trends in Recurrent Coronary Heart Disease after myocardial infarction among US women and men between 2008 and 2017. Circulation. 2021;143(7):650–60.CrossRefPubMed Peters SAE, Colantonio LD, Dai Y, Zhao H, Bittner V, Farkouh ME, et al. Trends in Recurrent Coronary Heart Disease after myocardial infarction among US women and men between 2008 and 2017. Circulation. 2021;143(7):650–60.CrossRefPubMed
20.
go back to reference Karagulova G, Yue Y, Moreyra A, Boutjdir M, Korichneva I. Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther. 2007;321:517–25.CrossRefPubMed Karagulova G, Yue Y, Moreyra A, Boutjdir M, Korichneva I. Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther. 2007;321:517–25.CrossRefPubMed
21.
22.
go back to reference Frustaci A, Sabbioni E, Fortaner S, Farina M, del Torchio R, Tafani M, et al. Selenium- and zinc- deficient cardiomyopathy in human intestinal malabsorption: preliminary results of selenium/zinc infusion. Eur J Heart Fail. 2012;14:202–10.CrossRefPubMed Frustaci A, Sabbioni E, Fortaner S, Farina M, del Torchio R, Tafani M, et al. Selenium- and zinc- deficient cardiomyopathy in human intestinal malabsorption: preliminary results of selenium/zinc infusion. Eur J Heart Fail. 2012;14:202–10.CrossRefPubMed
Metadata
Title
Serum zinc concentration in patients with myocardial infarction: a retrospective study
Authors
Atsushi Tanita
Shigeto Namiuchi
Kenta Onodera
Shinichiro Sunamura
Tsuyoshi Ogata
Kazuki Noda
Toru Takii
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-024-03776-4

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue